W
Wenqing Li
Researcher at Ohio State University
Publications - 21
Citations - 727
Wenqing Li is an academic researcher from Ohio State University. The author has contributed to research in topics: Medicine & Trans-activating crRNA. The author has an hindex of 10, co-authored 18 publications receiving 313 citations.
Papers
More filters
Journal ArticleDOI
Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis
Xucheng Hou,Xinfu Zhang,Xinfu Zhang,Weiyu Zhao,Chunxi Zeng,Binbin Deng,David W. McComb,Shi Du,Chengxiang Zhang,Wenqing Li,Yizhou Dong +10 more
TL;DR: It is shown that adoptive transfer of macrophages containing antimicrobial peptides linked to cathepsin B in the lysosomes can be applied for the treatment of multidrug-resistant bacteria-induced sepsis in mice with immunosuppression.
Journal ArticleDOI
Long-term storage of lipid-like nanoparticles for mRNA delivery
Pengxuan Zhao,Pengxuan Zhao,Xucheng Hou,Jingyue Yan,Shi Du,Yonger Xue,Wenqing Li,Guangya Xiang,Yizhou Dong +8 more
TL;DR: This study investigated a series of conditions for the long-term storage of LLNs with encapsulation of mRNA, and found that the addition with 5% sucrose or trehalose to LLNs could remain their mRNA delivery efficiency for at least three months in the liquid nitrogen storage condition.
Journal ArticleDOI
Ratiometric fluorescent probes for capturing endogenous hypochlorous acid in the lungs of mice
Xinfu Zhang,Xinfu Zhang,Weiyu Zhao,Bin Li,Wenqing Li,Chengxiang Zhang,Xucheng Hou,Justin Jiang,Yizhou Dong +8 more
TL;DR: A ratiometric fluorescent probe effectively captured endogenous HClO in the lungs of a lipopolysaccharide (LPS)-induced lung inflammation mouse model after intravenous administration.
Journal ArticleDOI
Recent advances of antibody drug conjugates for clinical applications.
Pengxuan Zhao,Pengxuan Zhao,Yuebao Zhang,Wenqing Li,Christopher Jeanty,Christopher Jeanty,Guangya Xiang,Yizhou Dong +7 more
TL;DR: This review summarizes the key elements of ADCs and highlights recent advances ofADCs, as well as important lessons learned from clinical data, and future directions.
Journal ArticleDOI
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing
Xinfu Zhang,Xinfu Zhang,Weiyu Zhao,Giang N. Nguyen,Chengxiang Zhang,Chunxi Zeng,Jingyue Yan,Shi Du,Xucheng Hou,Wenqing Li,Justin Jiang,Binbin Deng,David W. McComb,Robert Dorkin,Aalok Shah,Luis A. Barrera,Francine Gregoire,Manmohan Singh,Delai Chen,Denise E. Sabatino,Denise E. Sabatino,Yizhou Dong +21 more
TL;DR: A series of lipid-like nanomaterials (LLNs), named functionalized TT derivatives (FTT), are constructed for mRNA-based therapeutic applications in vivo, and FTT5 LLNs demonstrated high percentage of base editing on PCSK9 in vivo at a low dose of base editor mRNA and single guide RNA.